Homeopathic Oscillococcinum^®for preventing and treating influenza and influenza-like illness

Veterinary homeopathy: systematic review of medical conditions studied by randomised placebo‐controlled trials

“…Neither gloom nor glee is indicated here for either side of the polarised argument: matters will be settled only in the event of more and much better-quality research. Similar cautionary notes about the limited quality and clarity of the available evidence in homeopathy were applied in a recent Cochrane review – involving one of the current authors – of homeopathic Oscillococcinum for influenza in humans (Mathie and others 2012a). …”

Veterinary homeopathy: systematic review of medical conditions studied by randomised placebo‐controlled trials

“…Neither gloom nor glee is indicated here for either side of the polarised argument: matters will be settled only in the event of more and much better-quality research. Similar cautionary notes about the limited quality and clarity of the available evidence in homeopathy were applied in a recent Cochrane review – involving one of the current authors – of homeopathic Oscillococcinum for influenza in humans (Mathie and others 2012a). …”

The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever

“…31 The current trial evidence in children on the homeopathic treatment of URTI concerns the prevention of URTI 32-35 and the treatment of chronic recurrent URTI. 36 Moreover, there exists evidence for the treatment of other conditions that can include URTI, 37-40 and some non–controlled studies are available that contain promising data on the treatment of chronic URTI, 41 cough, 42 and the safety of a complex homeopathic medicine in the treatment of acute respiratory tract infections. 43 A comparative cohort study conducted in France showed that homeopathically managed patients with URTI had significantly lower consumption of antibiotics compared to conventionally managed patients, while achieving comparable clinical outcomes, 44 pointing to potential benefits from a health economic perspective and to decrease the public health risk related to antibiotic resistance.…”

Oscillococcinum leading to angioedema, a rare adverse event

“…A Cochrane review in 2015 on oscillococcinum concluded that the evidence regarding its use in prevention or treatment of influenza or influenza-like illness was insufficient. They could not rule out a possibility that the drug could have a clinically useful treatment effect, but termed the evidence non-compelling based on the low quality of eligible studies 5…”

Veterinary homeopathy: systematic review of medical conditions studied by randomised placebo‐controlled trials

“…Neither gloom nor glee is indicated here for either side of the polarised argument: matters will be settled only in the event of more and much better-quality research. Similar cautionary notes about the limited quality and clarity of the available evidence in homeopathy were applied in a recent Cochrane review – involving one of the current authors – of homeopathic Oscillococcinum for influenza in humans (Mathie and others 2012a). …”

The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever

“…31 The current trial evidence in children on the homeopathic treatment of URTI concerns the prevention of URTI 32-35 and the treatment of chronic recurrent URTI. 36 Moreover, there exists evidence for the treatment of other conditions that can include URTI, 37-40 and some non–controlled studies are available that contain promising data on the treatment of chronic URTI, 41 cough, 42 and the safety of a complex homeopathic medicine in the treatment of acute respiratory tract infections. 43 A comparative cohort study conducted in France showed that homeopathically managed patients with URTI had significantly lower consumption of antibiotics compared to conventionally managed patients, while achieving comparable clinical outcomes, 44 pointing to potential benefits from a health economic perspective and to decrease the public health risk related to antibiotic resistance.…”

Oscillococcinum leading to angioedema, a rare adverse event

“…A Cochrane review in 2015 on oscillococcinum concluded that the evidence regarding its use in prevention or treatment of influenza or influenza-like illness was insufficient. They could not rule out a possibility that the drug could have a clinically useful treatment effect, but termed the evidence non-compelling based on the low quality of eligible studies 5…”

Veterinary homeopathy: systematic review of medical conditions studied by randomised placebo‐controlled trials

“…Neither gloom nor glee is indicated here for either side of the polarised argument: matters will be settled only in the event of more and much better-quality research. Similar cautionary notes about the limited quality and clarity of the available evidence in homeopathy were applied in a recent Cochrane review – involving one of the current authors – of homeopathic Oscillococcinum for influenza in humans (Mathie and others 2012a). …”

The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever

“…31 The current trial evidence in children on the homeopathic treatment of URTI concerns the prevention of URTI 32-35 and the treatment of chronic recurrent URTI. 36 Moreover, there exists evidence for the treatment of other conditions that can include URTI, 37-40 and some non–controlled studies are available that contain promising data on the treatment of chronic URTI, 41 cough, 42 and the safety of a complex homeopathic medicine in the treatment of acute respiratory tract infections. 43 A comparative cohort study conducted in France showed that homeopathically managed patients with URTI had significantly lower consumption of antibiotics compared to conventionally managed patients, while achieving comparable clinical outcomes, 44 pointing to potential benefits from a health economic perspective and to decrease the public health risk related to antibiotic resistance.…”

Oscillococcinum leading to angioedema, a rare adverse event

“…A Cochrane review in 2015 on oscillococcinum concluded that the evidence regarding its use in prevention or treatment of influenza or influenza-like illness was insufficient. They could not rule out a possibility that the drug could have a clinically useful treatment effect, but termed the evidence non-compelling based on the low quality of eligible studies 5…”